These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19592665)

  • 1. Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors.
    Swingle MR; Amable L; Lawhorn BG; Buck SB; Burke CP; Ratti P; Fischer KL; Boger DL; Honkanen RE
    J Pharmacol Exp Ther; 2009 Oct; 331(1):45-53. PubMed ID: 19592665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total synthesis and evaluation of cytostatin, its C10-C11 diastereomers, and additional key analogues: impact on PP2A inhibition.
    Lawhorn BG; Boga SB; Wolkenberg SE; Colby DA; Gauss CM; Swingle MR; Amable L; Honkanen RE; Boger DL
    J Am Chem Soc; 2006 Dec; 128(51):16720-32. PubMed ID: 17177422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of the beta12-beta13 loop in protein phosphatase-1 catalytic subunit for inhibition by toxins and mammalian protein inhibitors.
    Connor JH; Kleeman T; Barik S; Honkanen RE; Shenolikar S
    J Biol Chem; 1999 Aug; 274(32):22366-72. PubMed ID: 10428807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fundamental role of the fostriecin unsaturated lactone and implications for selective protein phosphatase inhibition.
    Buck SB; Hardouin C; Ichikawa S; Soenen DR; Gauss CM; Hwang I; Swingle MR; Bonness KM; Honkanen RE; Boger DL
    J Am Chem Soc; 2003 Dec; 125(51):15694-5. PubMed ID: 14677930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predicted beta12-beta13 loop is important for inhibition of PP2Acalpha by the antitumor drug fostriecin.
    Evans DR; Simon JA
    FEBS Lett; 2001 Jun; 498(1):110-5. PubMed ID: 11389908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A.
    Walsh AH; Cheng A; Honkanen RE
    FEBS Lett; 1997 Oct; 416(3):230-4. PubMed ID: 9373158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of Ser/Thr phosphatase 4 (PP4C/PPP4C) mimics a novel post-mitotic action of fostriecin, producing mitotic slippage followed by tetraploid cell death.
    Theobald B; Bonness K; Musiyenko A; Andrews JF; Urban G; Huang X; Dean NM; Honkanen RE
    Mol Cancer Res; 2013 Aug; 11(8):845-55. PubMed ID: 23671329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures and mutagenesis of PPP-family ser/thr protein phosphatases elucidate the selectivity of cantharidin and novel norcantharidin-based inhibitors of PP5C.
    Chattopadhyay D; Swingle MR; Salter EA; Wood E; D'Arcy B; Zivanov C; Abney K; Musiyenko A; Rusin SF; Kettenbach A; Yet L; Schroeder CE; Golden JE; Dunham WH; Gingras AC; Banerjee S; Forbes D; Wierzbicki A; Honkanen RE
    Biochem Pharmacol; 2016 Jun; 109():14-26. PubMed ID: 27002182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of PP2A, but not PP5, mediates p53 activation by low levels of okadaic acid in rat liver epithelial cells.
    Messner DJ; Romeo C; Boynton A; Rossie S
    J Cell Biochem; 2006 Sep; 99(1):241-55. PubMed ID: 16598789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total synthesis and biological evaluation of the protein phosphatase 2A inhibitor cytostatin and analogues.
    Bialy L; Waldmann H
    Chemistry; 2004 Jun; 10(11):2759-80. PubMed ID: 15195307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fostriecin: chemistry and biology.
    Lewy DS; Gauss CM; Soenen DR; Boger DL
    Curr Med Chem; 2002 Nov; 9(22):2005-32. PubMed ID: 12369868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytostatin, an inhibitor of cell adhesion to extracellular matrix, selectively inhibits protein phosphatase 2A.
    Kawada M; Amemiya M; Ishizuka M; Takeuchi T
    Biochim Biophys Acta; 1999 Nov; 1452(2):209-17. PubMed ID: 10559474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia.
    Weinbrenner C; Baines CP; Liu GS; Armstrong SC; Ganote CE; Walsh AH; Honkanen RE; Cohen MV; Downey JM
    Circulation; 1998 Sep; 98(9):899-905. PubMed ID: 9738645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor antibiotic fostriecin covalently binds to cysteine-269 residue of protein phosphatase 2A catalytic subunit in mammalian cells.
    Takeuchi T; Takahashi N; Ishi K; Kusayanagi T; Kuramochi K; Sugawara F
    Bioorg Med Chem; 2009 Dec; 17(23):8113-22. PubMed ID: 19857968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor phosphorylation and activity are regulated by an association with protein phosphatase 1.
    Chen S; Kesler CT; Paschal BM; Balk SP
    J Biol Chem; 2009 Sep; 284(38):25576-84. PubMed ID: 19622840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein phosphatase 1 regulation by inhibitors and targeting subunits.
    Watanabe T; Huang HB; Horiuchi A; da Cruze Silva EF; Hsieh-Wilson L; Allen PB; Shenolikar S; Greengard P; Nairn AC
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3080-5. PubMed ID: 11248035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein phosphatase 2A dephosphorylates CaBP4 and regulates CaBP4 function.
    Haeseleer F; Sokal I; Gregory FD; Lee A
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1214-26. PubMed ID: 23341017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a robust and sensitive assay for the discovery of selective inhibitors for serine/threonine protein phosphatases PP1α (PPP1C) and PP5 (PPP5C).
    Swingle MR; Honkanen RE
    Assay Drug Dev Technol; 2014 Oct; 12(8):481-96. PubMed ID: 25383722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potent protein phosphatase 2A inhibitors aminocytostatins: new derivatives of cytostatin.
    Tohyama S; Kawada M; Muramatsu H; Hatano M; Inoue H; Matoba K; Sawa R; Igarashi M
    J Antibiot (Tokyo); 2021 Oct; 74(10):743-751. PubMed ID: 34290381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beta12-beta13 loop of protein phosphatase-1 is involved in activity regulation.
    Xie X; Xue C; Huang W; Wei Q
    IUBMB Life; 2006 Aug; 58(8):487-92. PubMed ID: 16916787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.